Teligent Stock Price, News & Analysis (NASDAQ:TLGT)

$3.14 +0.01 (+0.32 %)
(As of 02/18/2018 04:00 PM ET)
Previous Close$3.14
Today's Range$3.01 - $3.16
52-Week Range$2.75 - $9.54
Volume1.30 million shs
Average Volume457,257 shs
Market Capitalization$167.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07

About Teligent (NASDAQ:TLGT)

Teligent logoTeligent, Inc. is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 34 Abbreviated New Drug Application(ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2016.

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441

Debt

Debt-to-Equity Ratio2.23%
Current Ratio3.28%
Quick Ratio2.71%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E Growth62.8

Sales & Book Value

Annual Sales$66.88 million
Price / Sales2.51
Cash Flow$0.25 per share
Price / Cash12.61
Book Value$1.07 per share
Price / Book2.93

Profitability

Trailing EPS($0.23)
Net Income$-11,980,000.00
Net Margins-16.95%
Return on Equity-6.51%
Return on Assets-1.92%

Miscellaneous

Employees153
Outstanding Shares53,400,000

Teligent (NASDAQ:TLGT) Frequently Asked Questions

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

How were Teligent's earnings last quarter?

Teligent Inc (NASDAQ:TLGT) announced its quarterly earnings data on Monday, November, 6th. The company reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.07. The firm earned $13.65 million during the quarter, compared to the consensus estimate of $19.12 million. Teligent had a negative net margin of 16.95% and a negative return on equity of 6.51%. The firm's quarterly revenue was down 15.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.01 earnings per share. View Teligent's Earnings History.

Where is Teligent's stock going? Where will Teligent's stock price be in 2018?

3 brokerages have issued 1-year price targets for Teligent's shares. Their predictions range from $4.00 to $9.00. On average, they anticipate Teligent's stock price to reach $7.00 in the next year. View Analyst Ratings for Teligent.

What are Wall Street analysts saying about Teligent stock?

Here are some recent quotes from research analysts about Teligent stock:

  • 1. According to Zacks Investment Research, "Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. " (11/11/2017)
  • 2. Canaccord Genuity analysts commented, "We’re confident that the company’s revised expectations are achievable and delays at the agency will resolve in short order. We continue to view Teligent as a uniquely positioned generic company poised for meaningful growth over the next several years. We maintain our BUY rating and $11 price target on TLGT shares. Light revenue due to lidocaine ointment and Zantac; lidocaine solution a surprising star in the report. Teligent’s 2Q/17 revenue was $18.4 mm compared to our $19mm estimate and $20.3 mm consensus. In our post-launch thoughts, we believed investors were expecting a light quarter and potential downward revision to 2H/17 expectations. Adjusted loss per share was ($0.01) compared to our EPS estimate of +$0.01 and consensus of +$0.02. Teligent saw incremental competition and double-digit price erosion on lidocaine ointment and a return of a competitor on Zantac injection coupled with lower-than-expected Zantac utilization rates due to recent inventory shortages that changed physician use patterns." (8/8/2017)

Who are some of Teligent's key competitors?

Who are Teligent's key executives?

Teligent's management team includes the folowing people:

  • James C. Gale, Independent Chairman of the Board (Age 67)
  • Jason Grenfell-Gardner, President, Chief Executive Officer, Director (Age 42)
  • Damian Finio, Chief Financial Officer (Age 45)
  • Stephen Richardson, Chief Scientific Officer (Age 51)
  • Thomas J. Sabatino Jr., Director (Age 58)
  • Carole S. Ben-Maimon M.D., Independent Director (Age 58)
  • John E. Celentano, Independent Director (Age 57)
  • Bhaskar Chaudhuri Ph.D., Independent Director (Age 62)
  • Steven Hubrig Koehler, Independent Director (Age 66)

Who owns Teligent stock?

Teligent's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.52%), AMI Asset Management Corp (4.38%), Pembroke Management LTD (3.62%), Broadfin Capital LLC (3.61%), Kopp Investment Advisors LLC (1.79%) and Sanders Morris Harris LLC (1.52%). Company insiders that own Teligent stock include Carole Ben-Maimon, James C Gale, Jason Grenfell-Gardner, Jenniffer Collins, Stephen Richardson and Steven H Koehler. View Institutional Ownership Trends for Teligent.

Who sold Teligent stock? Who is selling Teligent stock?

Teligent's stock was sold by a variety of institutional investors in the last quarter, including Pembroke Management LTD, Citadel Advisors LLC, Sanders Morris Harris LLC, BlackRock Inc., Geode Capital Management LLC and Allianz Asset Management GmbH. View Insider Buying and Selling for Teligent.

Who bought Teligent stock? Who is buying Teligent stock?

Teligent's stock was purchased by a variety of institutional investors in the last quarter, including AMI Asset Management Corp, Broadfin Capital LLC, Kopp Investment Advisors LLC, Guggenheim Capital LLC, Deutsche Bank AG, UBS Asset Management Americas Inc., Two Sigma Investments LP and Teachers Advisors LLC. Company insiders that have bought Teligent stock in the last two years include Carole Ben-Maimon, James C Gale, Jason Grenfell-Gardner, Jenniffer Collins, Stephen Richardson and Steven H Koehler. View Insider Buying and Selling for Teligent.

How do I buy Teligent stock?

Shares of Teligent can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teligent's stock price today?

One share of Teligent stock can currently be purchased for approximately $3.14.

How big of a company is Teligent?

Teligent has a market capitalization of $167.68 million and generates $66.88 million in revenue each year. The company earns $-11,980,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis. Teligent employs 153 workers across the globe.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]


MarketBeat Community Rating for Teligent (TLGT)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  245
MarketBeat's community ratings are surveys of what our community members think about Teligent and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Teligent (NASDAQ:TLGT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.332.332.332.67
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.00$7.00$7.33$9.33
Price Target Upside: 83.25% upside83.25% upside39.68% upside45.38% upside

Teligent (NASDAQ:TLGT) Consensus Price Target History

Price Target History for Teligent (NASDAQ:TLGT)

Teligent (NASDAQ:TLGT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/9/2017Canaccord GenuitySet Price TargetHold$4.00HighView Rating Details
8/23/2017Roth CapitalSet Price TargetBuy$9.00LowView Rating Details
8/14/2017Deutsche BankLower Price TargetHold$9.00 -> $8.00LowView Rating Details
6/29/2016JMP SecuritiesInitiated CoverageHoldN/AView Rating Details
6/22/2016Raymond James FinancialInitiated CoverageStrong-Buy$11.00N/AView Rating Details
4/26/2016OppenheimerReiterated RatingHoldN/AView Rating Details
(Data available from 2/18/2016 forward)

Earnings

Teligent (NASDAQ:TLGT) Earnings History and Estimates Chart

Earnings by Quarter for Teligent (NASDAQ:TLGT)

Teligent (NASDAQ TLGT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017Q3 2017($0.01)($0.08)$19.12 million$13.65 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.02($0.02)$20.11 million$18.40 millionViewListenView Earnings Details
5/2/2017Q1 2017$0.02$0.05$21.03 million$19.89 millionViewN/AView Earnings Details
3/7/2017Q4 2016$0.01$17.97 million$17.90 millionViewListenView Earnings Details
10/27/2016Q3$0.00$0.01$16.90 million$16.20 millionViewListenView Earnings Details
7/28/2016Q2($0.02)$0.02$16.03 million$17.14 millionViewListenView Earnings Details
4/28/2016Q116($0.03)$0.02$14.33 million$15.70 millionViewN/AView Earnings Details
3/9/2016Q415($0.02)($0.02)$11.69 million$13.10 millionViewN/AView Earnings Details
10/22/2015Q3 2015($0.04)($0.02)$9.35 million$11.62 millionViewN/AView Earnings Details
7/23/2015Q2 2015($0.07)($0.05)$7.51 million$8.89 millionViewN/AView Earnings Details
3/2/2015Q4 2014$0.06$0.06$11.87 million$13.74 millionViewN/AView Earnings Details
7/24/2014Q2 2014($0.01)$6.61 million$6.48 millionViewN/AView Earnings Details
2/27/2014Q4 2013$0.01($0.01)$5.60 million$6.73 millionViewN/AView Earnings Details
7/25/2013Q2 2013($0.01)$3.82 millionViewN/AView Earnings Details
4/25/2013Q1 2013($0.01)$2.40 million$3.68 millionViewN/AView Earnings Details
3/5/2013Q4 2012($0.03)ViewN/AView Earnings Details
11/13/2012Q3 2012($0.02)ViewN/AView Earnings Details
8/13/2012Q2 2012($0.01)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.02)ViewN/AView Earnings Details
3/20/2012Q4 2011($0.01)ViewN/AView Earnings Details
11/21/2011Q3 2011($0.01)ViewN/AView Earnings Details
8/16/2011Q2 2011($0.02)ViewN/AView Earnings Details
4/1/2009Q4 2008($0.04)ViewN/AView Earnings Details
11/14/2008Q3 2008($0.04)ViewN/AView Earnings Details
8/13/2008Q2 2008($0.05)ViewN/AView Earnings Details
3/31/2008Q4 2007$0.02ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Teligent (NASDAQ:TLGT) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.2 EPS

Dividends

Dividend History for Teligent (NASDAQ:TLGT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Teligent (NASDAQ TLGT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 22.60%
Institutional Ownership Percentage: 70.48%
Insider Trades by Quarter for Teligent (NASDAQ:TLGT)
Institutional Ownership by Quarter for Teligent (NASDAQ:TLGT)

Teligent (NASDAQ TLGT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/13/2017Carole Ben-MaimonDirectorBuy5,000$3.48$17,400.002,400View SEC Filing  
11/10/2017Steven H KoehlerDirectorBuy5,000$3.62$18,100.001,800View SEC Filing  
11/9/2017Stephen RichardsonInsiderBuy6,410$3.13$20,063.3014,744View SEC Filing  
11/8/2017Jenniffer CollinsCFOBuy7,000$3.04$21,280.0019,206View SEC Filing  
3/11/2016James C GaleDirectorBuy15,000$4.91$73,650.0039,624View SEC Filing  
3/11/2016Jason Grenfell-GardnerCEOBuy10,500$4.82$50,610.00250,207View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Teligent (NASDAQ TLGT) News Headlines

Source:
DateHeadline
Teligent Inc (TLGT) Receives Average Recommendation of "Hold" from AnalystsTeligent Inc (TLGT) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 16 at 1:36 AM
Investor Expectations to Drive Momentum within Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, Teligent, and Versartis — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, Teligent, and Versartis — Discovering Underlying Factors of Influence
finance.yahoo.com - February 14 at 9:15 AM
Zacks: Analysts Expect Teligent Inc (TLGT) Will Announce Quarterly Sales of $13.54 MillionZacks: Analysts Expect Teligent Inc (TLGT) Will Announce Quarterly Sales of $13.54 Million
www.americanbankingnews.com - February 9 at 2:50 AM
Zacks: Analysts Expect Teligent Inc (TLGT) to Post -$0.11 Earnings Per ShareZacks: Analysts Expect Teligent Inc (TLGT) to Post -$0.11 Earnings Per Share
www.americanbankingnews.com - February 7 at 11:16 AM
Pernix Therapeutics (PTX) versus Teligent (TLGT) Head to Head ComparisonPernix Therapeutics (PTX) versus Teligent (TLGT) Head to Head Comparison
www.americanbankingnews.com - February 6 at 9:14 PM
Teligent (TLGT) Names Damian Finio as Chief Financial OfficerTeligent (TLGT) Names Damian Finio as Chief Financial Officer
www.streetinsider.com - January 27 at 9:39 AM
BRIEF-Teligent Appoints Damian Finio As Chief Financial OfficerBRIEF-Teligent Appoints Damian Finio As Chief Financial Officer
www.reuters.com - January 26 at 4:18 PM
Teligent, Inc. Announces the Appointment of Damian Finio as Chief Financial OfficerTeligent, Inc. Announces the Appointment of Damian Finio as Chief Financial Officer
finance.yahoo.com - January 26 at 9:22 AM
Teligent Inc (TLGT) Receives Consensus Rating of "Hold" from AnalystsTeligent Inc (TLGT) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - January 22 at 1:40 AM
Contrasting Teligent (TLGT) & Dr.Reddy's Laboratories (RDY)Contrasting Teligent (TLGT) & Dr.Reddy's Laboratories (RDY)
www.americanbankingnews.com - January 12 at 11:30 AM
 Analysts Expect Teligent, Inc. (TLGT) to Post -$0.11 Earnings Per Share Analysts Expect Teligent, Inc. (TLGT) to Post -$0.11 Earnings Per Share
www.americanbankingnews.com - January 4 at 5:28 PM
Critical Analysis: Teligent (TLGT) & Emergent Biosolutions (EBS)Critical Analysis: Teligent (TLGT) & Emergent Biosolutions (EBS)
www.americanbankingnews.com - January 2 at 5:28 AM
Teligent, Inc. (TLGT) Receives Average Recommendation of "Hold" from AnalystsTeligent, Inc. (TLGT) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 28 at 2:12 AM
ETFs with exposure to Teligent, Inc. : December 27, 2017ETFs with exposure to Teligent, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 12:59 PM
$13.54 Million in Sales Expected for Teligent, Inc. (TLGT) This Quarter$13.54 Million in Sales Expected for Teligent, Inc. (TLGT) This Quarter
www.americanbankingnews.com - December 21 at 7:58 PM
Teligent, Inc. (TLGT) Expected to Announce Earnings of -$0.11 Per ShareTeligent, Inc. (TLGT) Expected to Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - December 19 at 3:12 AM
Analyzing Teligent (TLGT) & Celgene (CELG)Analyzing Teligent (TLGT) & Celgene (CELG)
www.americanbankingnews.com - December 17 at 5:32 AM
Teva to lay off 14,000 workers in bid for survival — but some are skepticalTeva to lay off 14,000 workers in bid for survival — but some are skeptical
finance.yahoo.com - December 14 at 11:31 AM
Teligent (TLGT) PT Set at $4.00 by Canaccord GenuityTeligent (TLGT) PT Set at $4.00 by Canaccord Genuity
www.americanbankingnews.com - December 10 at 7:16 AM
Teligent, Inc. (TLGT) Expected to Post Quarterly Sales of $13.54 MillionTeligent, Inc. (TLGT) Expected to Post Quarterly Sales of $13.54 Million
www.americanbankingnews.com - December 3 at 9:06 AM
Teligent, Inc. (TLGT) Receives Average Rating of "Hold" from AnalystsTeligent, Inc. (TLGT) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 3 at 2:20 AM
ETFs with exposure to Teligent, Inc. : November 27, 2017ETFs with exposure to Teligent, Inc. : November 27, 2017
finance.yahoo.com - November 28 at 11:10 AM
Teligent, Inc. :TLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017Teligent, Inc. :TLGT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 24, 2017
finance.yahoo.com - November 24 at 6:17 PM
BRIEF-TELIGENT ANNOUNCES FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%BRIEF-TELIGENT ANNOUNCES FDA GENERIC APPROVAL OF HYDROCORTISONE BUTYRATE LOTION 0.1%
www.reuters.com - November 22 at 11:12 AM
Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%
finance.yahoo.com - November 22 at 11:12 AM
Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%Teligent, Inc. Announces FDA Approval of Erythromycin Topical Solution USP, 2%
finance.yahoo.com - November 21 at 11:52 AM
TLGT: Insiders vs. ShortsTLGT: Insiders vs. Shorts
www.thestreet.com - November 16 at 8:27 AM
Featured Company News - FDA Approved Teligents Betamethasone Dipropionate Ointment USP (Augmented), 0.05%Featured Company News - FDA Approved Teligent's Betamethasone Dipropionate Ointment USP (Augmented), 0.05%
finance.yahoo.com - November 14 at 10:06 AM
$16.92 Million in Sales Expected for Teligent, Inc. (TLGT) This Quarter$16.92 Million in Sales Expected for Teligent, Inc. (TLGT) This Quarter
www.americanbankingnews.com - November 14 at 6:24 AM
Teligent, Inc. (TLGT) Director Acquires $17,400.00 in StockTeligent, Inc. (TLGT) Director Acquires $17,400.00 in Stock
www.americanbankingnews.com - November 13 at 8:22 PM
Steven H. Koehler Purchases 5,000 Shares of Teligent, Inc. (TLGT) StockSteven H. Koehler Purchases 5,000 Shares of Teligent, Inc. (TLGT) Stock
www.americanbankingnews.com - November 13 at 8:21 PM
Insider Buying: Teligent, Inc. (TLGT) Insider Acquires 6,410 Shares of StockInsider Buying: Teligent, Inc. (TLGT) Insider Acquires 6,410 Shares of Stock
www.americanbankingnews.com - November 13 at 8:20 PM
 Brokerages Expect Teligent, Inc. (TLGT) Will Post Earnings of -$0.07 Per Share Brokerages Expect Teligent, Inc. (TLGT) Will Post Earnings of -$0.07 Per Share
www.americanbankingnews.com - November 12 at 3:36 PM
Teligent, Inc. (TLGT) Cut to Strong Sell at Zacks Investment ResearchTeligent, Inc. (TLGT) Cut to Strong Sell at Zacks Investment Research
www.americanbankingnews.com - November 11 at 8:10 AM
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%
finance.yahoo.com - November 10 at 2:48 PM
Teligent, Inc. (TLGT) CFO Jenniffer Collins Buys 7,000 SharesTeligent, Inc. (TLGT) CFO Jenniffer Collins Buys 7,000 Shares
www.americanbankingnews.com - November 9 at 9:12 AM
Pre-Open Movers 11/07: (CYRN) (WTW) (CLAR) Higher; (TLGT) (QTNA) (TRUE) Lower (more...)Pre-Open Movers 11/07: (CYRN) (WTW) (CLAR) Higher; (TLGT) (QTNA) (TRUE) Lower (more...)
www.streetinsider.com - November 7 at 3:26 PM
Mid-Day Market Update: U.S. Stocks Turn Lower; Kindred Healthcare Shares Rise After Q3 ResultsMid-Day Market Update: U.S. Stocks Turn Lower; Kindred Healthcare Shares Rise After Q3 Results
www.nasdaq.com - November 7 at 3:26 PM
Teligents (TLGT) CEO Jason Grenfell-Gardner on Q3 2017 Results - Earnings Call TranscriptTeligent's (TLGT) CEO Jason Grenfell-Gardner on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 3:26 PM
Here's Why Teligent Stock Was Cut Nearly in Half TodayHere's Why Teligent Stock Was Cut Nearly in Half Today
finance.yahoo.com - November 7 at 3:26 PM
Teligent, Inc. Announces Third Quarter 2017 ResultsTeligent, Inc. Announces Third Quarter 2017 Results
finance.yahoo.com - November 7 at 12:06 PM
Teligent reports 3Q lossTeligent reports 3Q loss
finance.yahoo.com - November 7 at 12:06 PM
Edited Transcript of TLGT earnings conference call or presentation 6-Nov-17 9:30pm GMTEdited Transcript of TLGT earnings conference call or presentation 6-Nov-17 9:30pm GMT
finance.yahoo.com - November 7 at 12:06 PM
Teligent shares drop nearly 40% after Q3 profit, revenue misses, lowered guidanceTeligent shares drop nearly 40% after Q3 profit, revenue misses, lowered guidance
finance.yahoo.com - November 7 at 12:05 PM
Teligent, Inc. (TLGT) Issues  Earnings ResultsTeligent, Inc. (TLGT) Issues Earnings Results
www.americanbankingnews.com - November 6 at 9:52 PM
Teligent, Inc. (TLGT) Downgraded by TheStreet to D+Teligent, Inc. (TLGT) Downgraded by TheStreet to D+
www.americanbankingnews.com - November 3 at 7:53 AM
Teligent, Inc. to Hold Conference Call for Third Quarter 2017 ResultsTeligent, Inc. to Hold Conference Call for Third Quarter 2017 Results
finance.yahoo.com - October 26 at 11:06 AM
Teligent Enters Oversold Territory (TLGT)Teligent Enters Oversold Territory (TLGT)
www.thestreet.com - October 25 at 9:40 PM
$19.17 Million in Sales Expected for Teligent, Inc. (TLGT) This Quarter$19.17 Million in Sales Expected for Teligent, Inc. (TLGT) This Quarter
www.americanbankingnews.com - October 25 at 3:42 PM
Teligent, Inc. breached its 50 day moving average in a Bearish Manner : TLGT-US : October 17, 2017Teligent, Inc. breached its 50 day moving average in a Bearish Manner : TLGT-US : October 17, 2017
finance.yahoo.com - October 18 at 9:35 AM

SEC Filings

Teligent (NASDAQ:TLGT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Teligent (NASDAQ:TLGT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Teligent (NASDAQ TLGT) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.